ArticleProceedings of the National Academy of Sciences of the United States of America2025

Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls.

Neda Sattarnezhad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.